Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

157.38
-1.6500-1.04%
Post-market: 158.000.6200+0.39%19:59 EDT
Volume:695.90K
Turnover:109.81M
Market Cap:21.12B
PE:-44.92
High:161.40
Open:160.14
Low:156.28
Close:159.03
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.45
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-94.76
PE(LYR):-47.40

Loading ...

Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41

Reuters
·
Jul 31

Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln

THOMSON REUTERS
·
Jul 31

Movement Alert|Guardant Health Inc. Rises 5.02% in Regular Trading, Bristol-Myers Squibb Cancer Drug Beat Lifts Oncology Diagnostics Sector

Market Focus
·
Jul 31

Guardant Health to Present at Canaccord Genuity Growth Conference Fireside Chat

Reuters
·
Jul 30

GH Research Initiated at Overweight by Wells Fargo

Dow Jones
·
Jul 27

GH Research initiated with an Overweight at Wells Fargo

TIPRANKS
·
Jul 27

Earning Preview: Guardant Health Inc. this quarter’s revenue is expected to increase by 48.77%, and institutional views are bullish

Earnings Agent
·
Jul 24

Movement Alert|Guardant Health Falls 5.06% in Regular Trading, Trading at $148.395

Market Focus
·
Jul 20

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64

Reuters
·
Jul 17

Movement Alert|Guardant Health Falls 5.02% in Regular Trading, Trading at $154.86

Market Focus
·
Jul 17

Guardant Health is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 16

Guardant Health price target raised to $190 from $160 at Guggenheim

TIPRANKS
·
Jul 16

Goldman Sachs Sticks to Their Buy Rating for Guardant Health (GH)

TIPRANKS
·
Jul 16

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)

TIPRANKS
·
Jul 15

Guardant Health is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 14

Guardant Health price target raised to $205 from $135 at Canaccord

TIPRANKS
·
Jul 14

Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals

GlobeNewswire
·
Jul 13

S&P 500 Futures Flat in Premarket Trading; Circle Internet Group, Moog Lead

Dow Jones
·
Jul 10

Cancer Blood Screen Spac's Merger is Delayed by Test's Results

Dow Jones
·
Jul 10

Guardant Health to Report Q2 2026 Results After Market Close, Host Conference Call

Reuters
·
Jul 10